Clinical Trial Update: Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an oral lyophilized fecal microbiota transplantation to prevent relapse or intestinal inflammation in adults with ulcerative c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Lyophilized Fecal Microbiota Transplantation (oral) (fecal microbiota transplantation)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Adults With Ulcerative Colitis | Phase 2 | Status: RECRUITING